ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2018

ASU 2014-09

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of impact of adoption on our condensed consolidated balance sheet and condensed consolidated statement of operations

Upon adoption of ASC 606, the cumulative effect of the changes made to our condensed consolidated balance sheet as of January 1, 2018 was as follows:

	December 31, 2017		Effects of		January 1, 2018
(in thousands)	As reported		Adoption		After adoption
Assets
Deferred income taxes	$	68,126	$	268	$	68,394
Liabilities
Accrued expenses and other current liabilities	$	66,308	$	1,027	$	67,335
Shareholders' Deficit
Accumulated deficit	$	(359,772)	$	(759)	$	(360,531)

In accordance with the new revenue standard requirements, the disclosure of the impact of adoption on our condensed consolidated statement of operations and condensed consolidated balance sheet is as follows:

	As of and for the Three Months Ended September 30, 2018
					Proformabalance
					without the
					adoption of
(in thousands)	As Reported		Effects of Adoption		ASC 606
Condensed Consolidated Statement of Operations
Net revenues	$	262,946	$	645	$	263,591
Other operating costs		30,999		736		31,735
Income from operations		15,924		(91)		15,833
Income before income taxes		6,809		(91)		6,718
Net income		4,369		(91)		4,278
Comprehensive income		6,133		(91)		6,042
Condensed Consolidated Balance Sheet
Assets
Deferred income taxes	$	71,967	$	24	$	71,991
Total assets		675,629		24		675,653
Liabilities
Accrued expenses and other current liabilities		54,790		92		54,882
Total current liabilities		148,872		92		148,964
Total liabilities		701,233		92		701,325
Shareholders' Deficit
Accumulated deficit		(365,852)		(68)		(365,920)
Total shareholders' deficit		(25,604)		(68)		(25,672)

	As of and for the Nine Months Ended September 30,2018
					Proforma balance
					without the
					adoption of
(in thousands)	As Reported		Effects of Adoption		ASC 606
Condensed Consolidated Statement of Operations
Net revenues	$	763,907	$	2,866	$	766,773
Other operating costs		92,631		2,937		95,568
Income from operations		36,876		(71)		36,805
Loss before income taxes		(9,169)		(71)		(9,240)
Net loss		(5,321)		(71)		(5,392)
Comprehensive loss		(3,799)		(71)		(3,870)
Condensed Consolidated Balance Sheet
Assets
Deferred income taxes	$	71,967	$	(249)	$	71,718
Total assets		675,629		(249)		675,380
Liabilities
Accrued expenses and other current liabilities		54,790		(956)		53,834
Total current liabilities		148,872		(956)		147,916
Total liabilities		701,233		(956)		700,277
Shareholders' Deficit
Accumulated deficit		(365,852)		707		(365,145)
Total shareholders' deficit		(25,604)		707		(24,897)

Patient Care

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of disaggregates of revenue from contracts with customers

	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
(in thousands)	2018		2017		2018		2017
Patient Care Segment
Medicare	$	69,724	$	65,759	$	197,461	$	186,606
Medicaid		33,597		32,557		96,993		95,524
Commercial Insurance/ Managed Care (excluding Medicare and Medicaid Managed Care)		78,333		79,804		226,761		234,866
Veterans Administration		19,317		18,662		56,873		52,995
Private Pay		13,109		13,855		42,657		44,504
Total	$	214,080	$	210,637	$	620,745	$	614,495

Products & Services

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Schedule of disaggregates of revenue from contracts with customers

	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
(in thousands)	2018		2017		2018		2017
Products & Services Segment
Distribution services, net of intersegment revenue eliminations	$	34,666	$	32,439	$	100,700	$	95,030
Therapeutic solutions		14,200		14,890		42,462		45,508
Total	$	48,866	$	47,329	$	143,162	$	140,538